Recently, the American Academy of Microbiology (AAM) officially announced the list of academicians of the American Institute of Microbiology in 2022. Among them, 4 people in the Chinese mainland were elected, namely Shu Yuelong, Huang Li, Lu Hongzhou, and Zhao Guoping.
As one of the subsidiaries of the American Society for Microbiology, the world's longest-standing life sciences organization, the American Academy of Microbiology is in a leading position in international microbial science, and selects academicians around the world every year to highlight their outstanding contributions in microbial scientific research or microbiology technical services and public welfare undertakings. Over the past 50 years, more than 2,600 scientists around the world have been elected to the American Academy of Microbiology, including Nobel Prizes, Lasker Prizes, and National Medalists of Science. A total of 65 scientists from Australia, Canada, China, Germany, Israel, Japan, Portugal, Switzerland, the United Kingdom and the United States were elected.
Yuelong Shu（舒跃龙）， Ph.D.， School of Public Health (Shenzhen)， Sun Yat-sen University；
Shu Yuelong, since April 2017, has been the Dean of the School of Public Health (Shenzhen) of Sun Yat-sen University. On April 23, 2021, he was selected into the list of valid people for the 2021 academician co-election of the Chinese Academy of Engineering.
Received the following awards:
1. Research and development and utilization of genetic components of the Herpesviridae family, First Prize for Scientific and Technological Progress of the Ministry of Health, 1998;
2. Development and Application of Novel Series Virus Vectors, Second Prize of National Science and Technology Progress Award, 1999;
3. Establishment and Application of Laboratory Monitoring Technology for Human Avian Influenza, Second Prize of Science and Technology of Chinese Preventive Medicine Association, 2007;
4. Clinical and Applied Basic Research on Influenza A(H1N1), First Prize of Beijing Science and Technology Award, 2011;
5. Research on the Etiology of Influenza A(H1N1) and Its Application in Influenza Pandemic Prevention and Control, First Prize of Science and Technology of Chinese Preventive Medicine Association, 2011;
6. Application of Pseudoviral Technology Platform in Influenza and Hepatitis C Virus Research and Drug/Immune Evaluation, Third Prize of Science and Technology of Chinese Preventive Medicine Association, 2011;
7. The first innovative research on the effective prevention and control of influenza A(H1N1) and the integration of the mainland, the first prize of the National Science and Technology Progress Award, 2014;
8. Discovery of human infection with novel H7N9 avian influenza virus and its etiology, First Prize of Chinese Medical Science and Technology, 2015;
9. Discovery of human infection with a new H7N9 avian influenza virus and its etiology, First Prize of Science and Technology Award of Chinese Preventive Medicine Association, 2015.
Li Huang（黄力）， Ph.D.， Institutes of Microbiology， Chinese Academy of Sciences (CAS)；
1999 Recipient of the National Outstanding Youth Fund
2006 Academic Leader of Innovation Group of national natural science foundation of China
Scientific Bulletin Editorial Board (2008-)
Extremophiles Managing Editor (2007-)
Acta Microbiologica Sinica Associate Editor (2007-)
Editorial Board Member, Chinese Journal of Biochemistry and Molecular Biology (2004-)
Main research areas: Genetic mechanisms of extreme thermophilic archaea
Hongzhou Lu（卢洪洲）， M.D.， Ph.D.， Shanghai Public Health Clinical Center， Fudan University；
Lu Hongzhou, Chief Physician, Second-level Professor, Adjunct Professor of School of Life Sciences, Fudan University, Doctor of Internal Medicine, Postdoctoral Fellow in the United States, Doctoral Supervisor of Internal Medicine, Doctoral Supervisor of Nursing, Director of Postdoctoral Mobile Station, Master of Public Health Supervisor. Selected as a national 100 million talents project, Yangtze River scholars, enjoy the special allowance of the State Council, "young and middle-aged experts with outstanding contributions". He is currently the Secretary of the Party Committee of Shanghai (Affiliated to Fudan University) Public Health Clinical Center, the Assistant President of Huashan Hospital Affiliated to Fudan University, the Former Chairman of the Tropical Diseases and Parasitics Branch of the Chinese Medical Association and the Leader of the AIDS Team, and the Vice Chairman of the Public Health Management Branch of the Medical Institutions of the Chinese Preventive Medicine Association.
Research interests: Diagnosis and treatment of infectious diseases and pathogenesis
Guoping Zhao（赵国屏）， Ph.D.， Institute of Plant Physiology and Ecology， Shanghai Institutes for Biological Sciences
Guoping Zhao, a molecular microbiologist, is mainly engaged in the regulation of microbial metabolism and the structural function relationship and reaction mechanism of enzymes. Born in August 1948, Shanghainese. He graduated from Fudan University in 1982 and received his Ph.D. from Purdue University in 1990. In 2005, he was elected as an academician of the Chinese Academy of Sciences. In 2011, he was elected a fellow of the Academy of Sciences of Developing Countries and in 2014, he was awarded an honorary doctorate by Purdue University.
Zhao Guoping is mainly engaged in the study of microbial physiological biochemistry, metabolic regulation and enzyme mechanism. Since 1998, he has led the establishment of genomics research platforms and systems, participated in the research of human disease genomes, and cloned a number of human genetic disease pathogenic genes. Launched research on biochips, bioinformatics, and proteomics; participated in the establishment of a human HapMap research technology platform. Initiated the sequencing of microbial genomes in China and presided over the research of genomes, functional genomes, comparative and evolutionary genomes of several important microorganisms. Academician Zhao Guoping actively explores the field of systematic synthetic biology research, and has made pioneering work in the regulation of microbial metabolism, including the study of acetylatation modification after translation of metabolic enzymes.
Academician Zhao Guoping led the major research project of the human genome of the Chinese Academy of Sciences in 1998; from 2001 to 2003, he completed the cloning of the disease-causing genes of milky teeth and the whole genome sequencing of the question mark leptospiratorium; from 2003 to 2005, he revealed the evolutionary mechanism of the SARS coronavirus; in 2010, he revealed that the metabolic enzyme "acetylation group" is a universal regulatory mechanism in organisms; in 2018, a number of cell factories were developed and the first case of "single-chromosome brewer's yeast" was constructed.
Source: Health Community
Author:Zhang Wenkang (Finishing)